In an effort to boost sales of Optison, Amersham Health has begun a new promotional campaign and is focusing on educational efforts aimed at expanding awareness and use of the echocardiography agent. The new campaign follows on the heels Mallinckrodt's
In an effort to boost sales of Optison, Amersham Health has begun a new promotional campaign and is focusing on educational efforts aimed at expanding awareness and use of the echocardiography agent. The new campaign follows on the heels Mallinckrodt's recent decision to terminate comarketing rights with Amersham regarding Optison.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.